APA (7th ed.) Citation

JE, A., K, P., A, D., L, G., N, D., C, H., . . . HM, E. (2024). The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer. Nature, 629(8014), 1142. https://doi.org/10.1038/s41586-024-07384-2

Chicago Style (17th ed.) Citation

JE, Abraham, et al. "The PARTNER Trial of Neoadjuvant Olaparib with Chemotherapy in Triple-negative Breast Cancer." Nature 629, no. 8014 (2024): 1142. https://doi.org/10.1038/s41586-024-07384-2.

MLA (9th ed.) Citation

JE, Abraham, et al. "The PARTNER Trial of Neoadjuvant Olaparib with Chemotherapy in Triple-negative Breast Cancer." Nature, vol. 629, no. 8014, 2024, p. 1142, https://doi.org/10.1038/s41586-024-07384-2.